The enemy within: Targeting host–parasite interaction for antileishmanial drug discovery

por Lamotte, Suzanne, Späth, Gerald F., Rachidi, Najma, Prina, Eric
Publicado 2017

Trifloxystrobin blocks the growth of Theileria parasites and is a promising drug to treat Buparvaquone resistance

por Villares, Marie, Lourenço, Nelly, Berthelet, Jeremy, Lamotte, Suzanne, Regad, Leslie, Medjkane, Souhila, Prina, Eric, Rodrigues-Lima, Fernando, Späth, Gerald F., Weitzman, Jonathan B.
Publicado 2022

Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth

por Chua, Ming Jang, Arnold, Megan S.J., Xu, Weijun, Lancelot, Julien, Lamotte, Suzanne, Späth, Gerald F., Prina, Eric, Pierce, Raymond J., Fairlie, David P., Skinner-Adams, Tina S., Andrews, Katherine T.
Publicado 2016

Effects of Structurally Different HDAC Inhibitors against Trypanosoma cruzi, Leishmania, and Schistosoma mansoni

por Di Bello, Elisabetta, Noce, Beatrice, Fioravanti, Rossella, Zwergel, Clemens, Valente, Sergio, Rotili, Dante, Fianco, Giulia, Trisciuoglio, Daniela, Mourão, Marina M., Sales, Policarpo, Lamotte, Suzanne, Prina, Eric, Späth, Gerald F., Häberli, Cécile, Keiser, Jennifer, Mai, Antonello
Publicado 2022